BioSpace News Archive

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that it has achieved full enrollment in its HELIOS-A Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis.

As the novel coronavirus outbreak in Wuhan spreads, Sunon Charity Foundation acted quickly and in unity to fight against this disease. On January 28, Sunon provided an initial $1.43million to relief and containment efforts.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate at the upcoming Cowen 40th Annual Health Care Conference.

Clinical Ink, a global clinical trial technology company, announces the addition of a new component to their Lumenis™ eSource Ecosystem

BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced that Gregg Stone, MD, of New York’s Mount Sinai Health System has signed on to the pivotal ALIVE Trial of the Revivent TC™ TransCatheter Ventricular Enhancement System as co-principal investigator.

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced Mary Anne Heino, President and Chief Executive Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference

RIVIERA BEACH, Fla. , Feb. 18, 2020 /PRNewswire/ -- Perry Baromedical Corporation , the international leader in hyperbaric medical device manufacturing for over 58 years is pleased to announce their acquisition of the hyperbaric division of Environmental Tectonics Corporation (ETC) of Southampton, PA which manufactures products under the “BARA-MED” brand. This business unit

Ischemia Care, LLC (Ischemia Care), an artificial intelligence company pioneering diagnostic blood tests for stroke, today appointed Edward C. Jauch, M.D. as chairman of the company’s clinical advisory board.

CareDx’s advertising obfuscates AlloSure’s poor performance

Awardees Selected for Their Commitment to Patients and Effort in Advancing the Pharmacy Profession